American Association for the Study of Liver Diseases

In this issue:

Genome-wide analysis of HCV-1 patients from IDEAL
Waitlist mortality in HBV liver transplant candidates
Tenofovir in spontaneous HBV reactivation
Taribavirin vs. ribavirin in HCV-1
A highly immunogenic T-cell vaccine for HCV
Adding NAC to corticosteroids in AAH
Early transplantation in corticosteroid nonresponders with AAH
PROGRESS: increasing doses in high weight/viral
load HCV-1 patients
Adding boceprevir to peg-IFN/ribavirin null responders
PROVE3: SVR with telaprevir-based regimens in HCV-1

Please login below to download this issue (PDF)